0000899243-20-019856.txt : 20200721
0000899243-20-019856.hdr.sgml : 20200721
20200721192943
ACCESSION NUMBER: 0000899243-20-019856
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200717
FILED AS OF DATE: 20200721
DATE AS OF CHANGE: 20200721
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Frail Donald
CENTRAL INDEX KEY: 0001817514
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39381
FILM NUMBER: 201039929
MAIL ADDRESS:
STREET 1: C/O PANDION THERAPEUTICS, INC.
STREET 2: 134 COOLIDGE AVE., 2ND FLOOR
CITY: WATERTOWN
STATE: MA
ZIP: 02472
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Pandion Therapeutics, Inc.
CENTRAL INDEX KEY: 0001807901
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 833015614
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 134 COOLIDGE AVENUE
STREET 2: 2ND FLOOR
CITY: WATERTOWN
STATE: MA
ZIP: 02472
BUSINESS PHONE: 617-393-5925
MAIL ADDRESS:
STREET 1: 134 COOLIDGE AVENUE
STREET 2: 2ND FLOOR
CITY: WATERTOWN
STATE: MA
ZIP: 02472
FORMER COMPANY:
FORMER CONFORMED NAME: Pandion Therapeutics Holdco LLC
DATE OF NAME CHANGE: 20200327
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-07-17
0
0001807901
Pandion Therapeutics, Inc.
PAND
0001817514
Frail Donald
C/O PANDION THERAPEUTICS, INC.,
134 COOLIDGE AVENUE
WATERTOWN
MA
02472
1
0
0
0
Common Stock
2020-07-21
4
C
0
11741
A
51113
D
Common Stock
2020-07-21
4
P
0
10000
18.00
A
61113
D
Stock Option (right to buy)
18.00
2020-07-17
4
A
0
4750
0.00
A
2030-07-16
Common Stock
4750
4750
D
Stock Option (right to buy)
18.00
2020-07-17
4
A
0
13997
0.00
A
2030-07-16
Common Stock
13997
13997
D
Series B Preferred Stock
2020-07-21
4
C
0
59872
0.00
D
Common Stock
11741
0
D
The Series B Preferred Stock converted into Common Stock on a 5.0994-for-one basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series B Preferred Stock was convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date.
Represents shares purchased through a directed share program in connection with the initial public offering of Pandion Therapeutics, Inc.'s common stock, which closed on July 21, 2020. These shares of common stock were purchased at the public offering price of $18.00 per share.
This option award was granted on July 17, 2020. 1/4 of the shares underlying the award shall vest on September 27, 2020, with the remainder of the shares vesting in equal monthly installments following September 27, 2020 through September 27, 2023, subject to the reporting person's continued service on each applicable vesting date.
This option award was granted on July 17, 2020. The shares underlying the award vest in equal monthly installments following July 17, 2020 through July 17, 2023, subject to the reporting person's continued service on each applicable vesting date.
/s/ Edward Freedman, as attorney-in-fact for Donald E. Frail
2020-07-21